UnknownNot Applicable

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

United States53 participantsStarted 2012-10-09

Plain-language summary

The study aims to identify predictors of disease in patients with hyperparathyroidism (HPTH) who undergo surgery.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. MEN1 patients who have undergone parathyroidectomy and did not develop PNET.
✓. MEN1 patients who have undergone parathyroidectomy and had surgical removal of PNET.

What they're measuring

Identification of Somatic Mutations and Inherited Genetic Variants to Help Predict the Development of Pancreatic Neuroendocrine Tumors (PNET) in Participants with Hyperparathyroidism by Genome Sequencing

Timeframe: 10 years

Trial details

NCT IDNCT03053999

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-10

Contact for this trial

Nancy D. Perrier, MD

713-792-6940 NPerrier@mdanderson.org

View on ClinicalTrials.gov More Multiple Endocrine Neoplasia trials